Capital International’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $12M | Buy |
427,700
+10,201
| +2% | +$272K | 0.45% | 60 |
|
|
2025
Q4 | $10.4M | Buy |
417,499
+154,008
| +58% | +$3.88M | 0.37% | 74 |
|
|
2025
Q3 | $6.71M | Hold |
263,491
| – | – | 0.24% | 93 |
|
|
2025
Q2 | $6.39M | Hold |
263,491
| – | – | 0.24% | 90 |
|
|
2025
Q1 | $6.68M | Buy |
263,491
+10,218
| +4% | +$267K | 0.29% | 88 |
|
|
2024
Q4 | $6.72M | Buy |
253,273
+8,509
| +3% | +$231K | 0.27% | 87 |
|
|
2024
Q3 | $7.08M | Hold |
244,764
| – | – | 0.31% | 88 |
|
|
2024
Q2 | $6.85M | Buy |
244,764
+27,027
| +12% | +$744K | 0.32% | 80 |
|
|
2024
Q1 | $6.04M | Sell |
217,737
-153,599
| -41% | -$4.26M | 0.29% | 94 |
|
|
2023
Q4 | $10.7M | Buy |
371,336
+7,991
| +2% | +$242K | 0.55% | 64 |
|
|
2023
Q3 | $12.1M | Buy |
363,345
+16,497
| +5% | +$583K | 0.69% | 48 |
|
|
2023
Q2 | $12.7M | Buy |
346,848
+532
| +0.2% | +$20.7K | 0.71% | 46 |
|
|
2023
Q1 | $14.1M | Buy |
346,316
+15,922
| +5% | +$688K | 0.85% | 33 |
|
|
2022
Q4 | $16.9M | Buy |
330,394
+10,987
| +3% | +$527K | 1.17% | 23 |
|
|
2022
Q3 | $14M | Buy |
319,407
+36,468
| +13% | +$1.77M | 0.97% | 26 |
|
|
2022
Q2 | $14.8M | Buy |
282,939
+2,777
| +1% | +$142K | 1.12% | 23 |
|
|
2022
Q1 | $14.5M | Buy |
280,162
+106,108
| +61% | +$5.51M | 0.83% | 28 |
|
|
2021
Q4 | $10.3M | Sell |
174,054
-818
| -0.5% | -$40.5K | 0.52% | 57 |
|
|
2021
Q3 | $7.52M | Sell |
174,872
-1,868
| -1% | -$82.8K | 0.41% | 71 |
|
|
2021
Q2 | $6.92M | Sell |
176,740
-99,896
| -36% | -$3.88M | 0.38% | 67 |
|
|
2021
Q1 | $10M | Sell |
276,636
-76,354
| -22% | -$2.71M | 0.61% | 46 |
|
|
2020
Q4 | $13M | Buy |
352,990
+2,951
| +0.8% | +$108K | 0.76% | 34 |
|
|
2020
Q3 | $12.2M | Buy |
350,039
+139,055
| +66% | +$4.88M | 0.83% | 32 |
|
|
2020
Q2 | $6.55M | Sell |
210,984
-720
| -0.3% | -$24.5K | 0.61% | 44 |
|
|
2020
Q1 | $6.56M | Sell |
211,704
-70,250
| -25% | -$2.39M | 0.74% | 37 |
|
|
2019
Q4 | $10.5M | Buy |
281,954
+133,634
| +90% | +$4.76M | 1.1% | 22 |
|
|
2019
Q3 | $5.06M | Buy |
148,320
+30,551
| +26% | +$1.11M | 0.76% | 37 |
|
|
2019
Q2 | $4.84M | Sell |
117,769
-1,077
| -0.9% | -$42.8K | 1.15% | 23 |
|
|
2019
Q1 | $4.79M | Buy |
118,846
+24,513
| +26% | +$982K | 1.15% | 25 |
|
|
2018
Q4 | $3.91M | Buy |
94,333
+82,634
| +706% | +$3.43M | 1.06% | 28 |
|
|
2018
Q3 | $489K | Hold |
11,699
| – | – | 0.15% | 107 |
|
|
2018
Q2 | $403K | Hold |
11,699
| – | – | 0.07% | 160 |
|
|
2018
Q1 | $394K | Hold |
11,699
| – | – | 0.07% | 159 |
|
|
2017
Q4 | $402K | Hold |
11,699
| – | – | 0.08% | 143 |
|
|
2017
Q3 | $396K | Sell |
11,699
-65,348
| -85% | -$2.1M | 0.03% | 104 |
|
|
2017
Q2 | $2.46M | Hold |
77,047
| – | – | 0.16% | 90 |
|
|
2017
Q1 | $2.5M | Buy |
77,047
+5,270
| +7% | +$166K | 0.16% | 89 |
|
|
2016
Q4 | $2.21M | Sell |
71,777
-52,490
| -42% | -$1.6M | 0.15% | 93 |
|
|
2016
Q3 | $3.99M | Buy |
124,267
+20,553
| +20% | +$687K | 0.28% | 84 |
|
|
2016
Q2 | $3.46M | Sell |
103,714
-25,928
| -20% | -$828K | 0.25% | 88 |
|
|
2016
Q1 | $3.65M | Buy |
129,642
+38,155
| +42% | +$1.09M | 0.24% | 91 |
|
|
2015
Q4 | $2.8M | Hold |
91,487
| – | – | 0.18% | 100 |
|
|
2015
Q3 | $2.73M | Hold |
91,487
| – | – | 0.18% | 95 |
|
|
2015
Q2 | $2.91M | Sell |
91,487
-3,268
| -3% | -$107K | 0.17% | 103 |
|
|
2015
Q1 | $3.13M | Buy |
94,755
+4,849
| +5% | +$154K | 0.19% | 95 |
|
|
2014
Q4 | $2.66M | Hold |
89,906
| – | – | 0.16% | 95 |
|
|
2014
Q3 | $2.52M | Buy |
89,906
+30,460
| +51% | +$855K | 0.16% | 93 |
|
|
2014
Q2 | $1.67M | Hold |
59,446
| – | – | 0.1% | 106 |
|
|
2014
Q1 | $1.81M | Sell |
59,446
-421
| -0.7% | -$12.6K | 0.11% | 104 |
|
|
2013
Q4 | $1.74M | Sell |
59,867
-2,319
| -4% | -$67.5K | 0.11% | 105 |
|
|
2013
Q3 | $1.69M | Hold |
62,186
| – | – | 0.11% | 99 |
|
|
2013
Q2 | $1.65M | Buy |
+62,186
| New | +$1.72M | 0.1% | 100 |
|
Other funds holding PFE
VCM
VPM
Capital International's PFE Position: Q1 2026 in Review
Capital International increased its Pfizer (PFE) stake by 2.4% in Q1 2026, buying an estimated $272K and bringing the position to 427,700 shares worth $12M. The position accounts for 0.45% of the portfolio, ranked #60.
Capital International first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $16.9M in Q4 2022. 2,933 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Capital International held 427,700 shares of Pfizer worth $12M as of Q1 2026.
- Capital International bought 10,201 Pfizer shares in Q1 2026, an estimated $272K.
- Pfizer made up 0.45% of Capital International's portfolio in Q1 2026, its #60 holding.
- Capital International first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- Capital International's Pfizer position peaked at $16.9M in Q4 2022.
- 2,933 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Capital International's 13F filing for Q1 2026, filed 13 May 2026.